|
XIAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.638200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.714600E-01 |
| Normal-vs-Stage2 |
1.783980E-01 |
| Normal-vs-Stage3 |
8.416200E-03 |
| Normal-vs-Stage4 |
6.781600E-03 |
| Stage1-vs-Stage2 |
5.418000E-01 |
| Stage1-vs-Stage3 |
4.156200E-02 |
| Stage1-vs-Stage4 |
2.552200E-02 |
| Stage2-vs-Stage3 |
4.171200E-01 |
| Stage2-vs-Stage4 |
3.270000E-01 |
| Stage3-vs-Stage4 |
7.260200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.670500E-02 |
| Normal-vs-AfricanAmerican |
9.135800E-01 |
| Normal-vs-Asian |
5.795600E-02 |
| Caucasian-vs-AfricanAmerican |
2.231400E-01 |
| Caucasian-vs-Asian |
6.480000E-01 |
| AfricanAmerican-vs-Asian |
1.721170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.753900E-02 |
| Normal-vs-Female |
1.048030E-01 |
| Male-vs-Female |
6.407000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.203200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.731600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.700020E-02 |
| Normal-vs-Age(81-100Yrs) |
4.154400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.630300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.904400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.517000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.814000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.092200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.363400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.039000E-03 |
| Classical-VS-Follicular |
6.213800E-02 |
| Classical-VS-Other |
1.926450E-01 |
| Classical-VS-Normal |
3.721200E-01 |
| Tall-VS-Follicular |
1.374420E-01 |
| Tall-VS-Other |
9.329800E-01 |
| Tall-VS-Normal |
2.125000E-03 |
| Follicular-VS-Other |
5.486000E-01 |
| Follicular-VS-Normal |
4.797600E-02 |
| Other-VS-Normal |
9.885900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.312200E-02 |
| Normal-vs-N1 |
1.117930E-02 |
| N0-vs-N1 |
3.241000E-01 |
|
|
